CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 651311552
- Phone
- 858.875.1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | RASTETTER WILLIAM H Director | Option exercise | +25,000 | $1.69 | $42K | 36,331 |
| 2026-05-05 | RASTETTER WILLIAM H Director | Option exercise · Stock Option (Right to Buy) | +25,000 | 0 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other disposition · Cash-settled Swaps | −266,280 | 0 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other acquisition · Cash-settled Swaps | +266,280 | 502,769 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other disposition | −8,977,624 | 0 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other acquisition | +8,977,624 | 12,884,277 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other disposition · Pre-Funded Warrants to Purchase Common Stock | −3,691,324 | 0 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other acquisition · Pre-Funded Warrants to Purchase Common Stock | +3,691,324 | 3,893,674 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other disposition · Cash-settled Swaps | −266,280 | 0 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other acquisition · Cash-settled Swaps | +266,280 | 502,769 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other disposition · Class A Convertible Preferred Stock | −162,013 | 0 | ||
| 2026-04-20 | Redmile Group, LLC Director | Other acquisition · Class A Convertible Preferred Stock | +162,013 | 2,755,086 | ||
| 2026-01-15 | TAHL CINDY See Remarks | Grant or award | +100,000 | 487,081 | ||
| 2026-01-15 | TAHL CINDY See Remarks | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2026-01-15 | Adawi Kamal Chief Financial Officer | Grant or award | +25,000 | 100,000 | ||
| 2026-01-15 | Adawi Kamal Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-01-15 | Valamehr Bahram President and CEO | Grant or award | +335,000 | 664,708 | ||
| 2026-01-15 | Valamehr Bahram President and CEO | Grant or award · Stock Option (Right to Buy) | +1,300,000 | 1,300,000 | ||
| 2026-01-09 | TAHL CINDY See Remarks | Sale | −10,589 | $1.06 | $11K | 387,081 |
| 2026-01-09 | Valamehr Bahram President and CEO | Sale | −5,190 | $1.07 | $6K | 329,708 |
Page 2 of 8 · 144 trades